OBiO Technology (Shanghai) Corp., Ltd. is set to make a splash at the upcoming American Society of Gene & Cell Therapy conference in Maryland, USA. With a focus on showcasing their latest innovations in gene and cell therapy, OBiO Technology will present nine posters, highlighting three self-developed patented achievements, four process optimization advancements, and two cutting-edge technology introductions.
These presentations underscore OBiO Technology’s commitment to driving advancements in the gene therapy field by enhancing efficiency, refining processes, and lowering production costs. Their innovative solutions aim to provide dependable and cost-effective production methods that propel clinical projects forward.
“We are thrilled to bring our expertise to the ASGCT conference,” said Javier Jia Guo, Ph.D., Chief Executive Officer of OBiO Technology. “Our presentations exemplify our dedication to innovation and problem-solving in gene and cell therapy. We are constantly working to improve yield efficiency, streamline production processes, and drive cost efficiencies to benefit the industry as a whole.”
OBiO Technology, a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), offers a state-of-the-art facility spanning 830,000 sq.ft. Their focus on vectorology studies, functional genomics, and process and analytics development ensures readiness for Investigational New Drug (IND) applications, supporting all phases of clinical and commercial manufacturing.
With a mission to “Enable Gene Therapy for Better Lives,” OBiO Technology is dedicated to delivering high-quality services globally. From the laboratory to the clinic, their team is committed to advancing products that positively impact populations around the world.
Specializing in plasmids, mRNA, AAV, LVV, Ad viral vectors, cell therapy, and cutting-edge technologies like inducible viral vector packaging, OBiO Technology’s expertise covers a wide range of areas in the gene and cell therapy space.
For those attending the ASGCT conference, a visit to OBiO Technology’s booth #1644 is a must. Learn more about how their innovative solutions can accelerate development timelines, reduce manufacturing risks, and provide high-performance products while maintaining cost-effectiveness.
Don’t miss the opportunity to engage with the experts from OBiO Technology and discover how their cutting-edge services can support your gene and cell therapy projects. Visit their booth at the ASGCT conference to learn more about their latest achievements and advancements in the field.
Source link
